ClinicalTrials.gg
CompletedNCT05876208Updated Oct 16, 2026

Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform

An interventional study of BAND Connect's VirtuaCare™ platform and Standard of Care Physical Therapy in Shoulder Injuries, sponsored by University of Cincinnati. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by University of Cincinnati · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jul 2022, registered May 2023).
Updated Oct 16, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.

Enrollment
12th of 26
77 · median 64
Started
2022
with 4 others
No phase
20 of 39
7 open now
Registered
30th of 39
by date

Among the 39 studies in Shoulder Injuries with a site in United States, this one is the 12th largest by enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2022, is one of 20 with no phase, and was the 30th registered.

Shoulder Injuries

118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.

Browse Shoulder Injuries studies →

Open to participants now

14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Shoulder Injuries with a site in United States, or all of them as a file.
02

Study summary

This study aims to enhance at-home therapy by introducing a new device called the BAND Connect's VirtuaCare™ platform. The study aims to determine whether patients can improve their adherence to at-home exercises using this device. Currently, research indicates that only 35% of patients undergoing physical therapy treatment fully comply with their prescribed plans of care, often neglecting their at-home exercises. To address this issue, a set of smart exercise tools called VirtuaCare™ has been developed. This platform provides patients with instructions on performing at-home exercises and offers real-time biofeedback to help them adjust their form if necessary. The study seeks to evaluate the effectiveness of BAND CVCP in assisting patients and improving their overall success with at-home therapy.

Read the detailed description

This study aims to compare the effectiveness of the BAND CVCP device with the standard physical therapy regimens provided by UC Health Orthopaedic Surgery. Participants undergoing shoulder surgeries performed by Dr. Brian Grawe will be randomly assigned to one of two groups. Group 1 will utilize the BAND CVCP both in the clinic and at home as a supplement to their treatment protocols. Group 2 will receive standard physical therapy without the BAND CVCP.

In Group 1, participants will be given access to the BAND CVCP and necessary materials during their first physical therapy appointment. The physical therapist will guide them through exercises using the device, recording their actions and providing real-time feedback. The BAND CVCP app on their provided Android phone will offer instructions for each exercise, eliminating the need to memorize the routine.

During clinic visits, Group 1 participants' progress will be reviewed using the BAND CVCP participant report. The report will display information such as completed exercises, form, pace, range of motion, and exertion, which is measured by sensors in the BAND CVCP handles. The therapist will help participants understand any corrections needed for their at-home exercises and make adjustments to their rehabilitation plan accordingly.

Both Group 1 and Group 2 participants will complete patient report outcomes at different intervals, including pre-operative scores, weekly visual analog scale assessments, and monthly assessments such as the Upper Extremity Functional Index (UEFI) or Quick Disabilities of Arm, Shoulder, and Hand (QuickDASH). Group 1 participants will complete these forms using the BAND CVCP's phone application, while Group 2 participants will use paper copies at the clinic.

Additional assessments will be conducted at the 3-month, 6-month, and discharge from care visits, which include the ASES, SST, and EQ-5D-5L forms. Group 1 participants will complete these assessments on the BAND CVCP's phone application, while Group 2 participants will use paper copies at the clinic.

This study aims to evaluate the effectiveness of the BAND CVCP device compared to standard physical therapy regimens and track participant rehabilitation outcomes throughout the process.

03

Conditions studied

  • Shoulder Injuries

Browse trials for

Keywords

  • Rotator Cuff Repair
  • Anatomic and Reverse Total Shoulder
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Dr. Brian Grawe will perform surgery, and participants will be undergoing post-operative physical therapy rehabilitation at UC Health.
  • Primary total shoulder arthroplasty and primary reverse total shoulder arthroplasty or Primary rotator cuff repair
  • Outpatient physical therapy prescribed by the doctor for post-operative rehabilitation

Exclusion criteria

Exclusion Criteria:

  • Unplanned surgical procedure
  • Partial shoulder replacement or revision shoulder replacement
  • Revision rotator cuff repair
  • Fracture surgeries
  • Prior surgery within the last 5 years or less than 6 months between surgery on opposite shoulder
  • Length of stay in hospital greater than 3 days
  • Comorbidity: Uncontrolled diabetes patients; Diagnosed with cancer in the past 5 years or active disease; Any comorbidity that may impact compliance with the study protocol (completion of standard physical therapy rehabilitation procedures)
  • Injuries related to workers' compensation
  • Injuries involved in any pending litigation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    Group 1

    Group 1 will be using the BAND CVCP both in the clinic and at home to supplement the treatment protocols used in the clinic today.

    Other: BAND Connect's VirtuaCare™ platform

  • Placebo comparator
    Group 2

    Group 2 will receive standard-of-care physical therapy without the use of the BAND CVCP.

    Other: Standard of Care Physical Therapy

Interventions

  • OtherBAND Connect's VirtuaCare™ platform

    Band Connect provides a medical-grade and condition-specific platform that augments the clinician workflow by extending the in-clinic MSK rehabilitation experience into the patient's home - leading to higher quality personalized treatment and increased adherence with enhanced economics and reimbursement for the clinic.

  • OtherStandard of Care Physical Therapy

    Standard of care physical therapy without the use of the BAND CVCP

06

What researchers measure

Primary outcomes

  1. Number of Visits

    Number of visits with physical therapist

    Time frame: 12 weeks

07

Study locations

1 site
  • University of Cincinnati
    Cincinnati, Ohio 45267, United States
08

References and documents

Publications

  • Cuff DJ, Pupello DR. Prospective randomized study of arthroscopic rotator cuff repair using an early versus delayed postoperative physical therapy protocol. J Shoulder Elbow Surg. 2012 Nov;21(11):1450-5. doi: 10.1016/j.jse.2012.01.025. Epub 2012 May 2. PubMed 22554876 ↗
  • Dahl-Popolizio S, Loman J, Cordes CC. Comparing Outcomes of Kinect Videogame-Based Occupational/Physical Therapy Versus Usual Care. Games Health J. 2014 Jun;3(3):157-61. doi: 10.1089/g4h.2014.0002. Epub 2014 Apr 17. PubMed 26196174 ↗
  • Keener JD, Galatz LM, Stobbs-Cucchi G, Patton R, Yamaguchi K. Rehabilitation following arthroscopic rotator cuff repair: a prospective randomized trial of immobilization compared with early motion. J Bone Joint Surg Am. 2014 Jan 1;96(1):11-9. doi: 10.2106/JBJS.M.00034. PubMed 24382719 ↗
  • Palazzo C, Klinger E, Dorner V, Kadri A, Thierry O, Boumenir Y, Martin W, Poiraudeau S, Ville I. Barriers to home-based exercise program adherence with chronic low back pain: Patient expectations regarding new technologies. Ann Phys Rehabil Med. 2016 Apr;59(2):107-13. doi: 10.1016/j.rehab.2016.01.009. Epub 2016 Apr 1. PubMed 27050664 ↗
  • Raaben M, Holtslag HR, Leenen LPH, Augustine R, Blokhuis TJ. Real-time visual biofeedback during weight bearing improves therapy compliance in patients following lower extremity fractures. Gait Posture. 2018 Jan;59:206-210. doi: 10.1016/j.gaitpost.2017.10.022. Epub 2017 Oct 20. PubMed 29078134 ↗
  • Sluijs EM, Kok GJ, van der Zee J. Correlates of exercise compliance in physical therapy. Phys Ther. 1993 Nov;73(11):771-82; discussion 783-6. doi: 10.1093/ptj/73.11.771. PubMed 8234458 ↗
  • Arndt J, Clavert P, Mielcarek P, Bouchaib J, Meyer N, Kempf JF; French Society for Shoulder & Elbow (SOFEC). Immediate passive motion versus immobilization after endoscopic supraspinatus tendon repair: a prospective randomized study. Orthop Traumatol Surg Res. 2012 Oct;98(6 Suppl):S131-8. doi: 10.1016/j.otsr.2012.05.003. Epub 2012 Sep 1. PubMed 22944392 ↗
  • Denard PJ, Ladermann A, Burkhart SS. Prevention and management of stiffness after arthroscopic rotator cuff repair: systematic review and implications for rotator cuff healing. Arthroscopy. 2011 Jun;27(6):842-8. doi: 10.1016/j.arthro.2011.01.013. PubMed 21624680 ↗
  • Huberty DP, Schoolfield JD, Brady PC, Vadala AP, Arrigoni P, Burkhart SS. Incidence and treatment of postoperative stiffness following arthroscopic rotator cuff repair. Arthroscopy. 2009 Aug;25(8):880-90. doi: 10.1016/j.arthro.2009.01.018. PubMed 19664508 ↗
  • Koo SS, Parsley BK, Burkhart SS, Schoolfield JD. Reduction of postoperative stiffness after arthroscopic rotator cuff repair: results of a customized physical therapy regimen based on risk factors for stiffness. Arthroscopy. 2011 Feb;27(2):155-60. doi: 10.1016/j.arthro.2010.07.007. Epub 2010 Oct 20. PubMed 20970299 ↗
  • Carbonaro N, Lucchesi I, Lorusssi F, Tognetti A. Tele-monitoring and tele-rehabilitation of the shoulder muscular-skeletal diseases through wearable systems. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4410-4413. doi: 10.1109/EMBC.2018.8513371. PubMed 30441330 ↗
  • Brandao AF, Dias DR, Castellano G, Parizotto NA, Trevelin LC. RehabGesture: An Alternative Tool for Measuring Human Movement. Telemed J E Health. 2016 Jul;22(7):584-9. doi: 10.1089/tmj.2015.0139. Epub 2016 May 12. PubMed 27172389 ↗
  • Kennedy JS, Garrigues GE, Pozzi F, Zens MJ, Gaunt B, Phillips B, Bakshi A, Tate AR. The American Society of Shoulder and Elbow Therapists' consensus statement on rehabilitation for anatomic total shoulder arthroplasty. J Shoulder Elbow Surg. 2020 Oct;29(10):2149-2162. doi: 10.1016/j.jse.2020.05.019. Epub 2020 Jun 10. PubMed 32534209 ↗
  • Brameier DT, Hirscht A, Kowalsky MS, Sethi PM. Rehabilitation Strategies After Shoulder Arthroplasty in Young and Active Patients. Clin Sports Med. 2018 Oct;37(4):569-583. doi: 10.1016/j.csm.2018.05.007. PubMed 30201171 ↗
  • Ikard ST Jr, Farmer KW, Struk AM, Garvan CS, Gillespy A, Wright TW. Rotator Cuff Dysfunction after Anatomic Total Shoulder Arthroplasty: Who is at Risk? J Surg Orthop Adv. 2020 Spring;29(1):31-35. PubMed 32223863 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Apr 2026, 45 months.

Of 38 non-industry interventional studies with no phase under Shoulder Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's 45 months is above that.

Counting every sponsor, half of 43 studies reached it within 15 months; a quarter within 7 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Jan 2027 → Apr 2026 and completion Jul 2027 → Apr 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 16, 2023
First posted
May 25, 2023
StartActual
Jul 5, 2022
Primary completionActual
Apr 27, 2026was Jan 2027
CompletionActual
Apr 27, 2026was Jul 2027
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 16, 2026
Primary completion
Jan 1, 2027→Apr 27, 2026 (actual)
Oct 16, 2026
Study completion
Jul 31, 2027→Apr 27, 2026 (actual)
Oct 16, 2026
Enrollment
60 (estimated)→77 (actual)
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Recruiting→Completed
    Primary completion Jan 1, 2027→Apr 27, 2026 (now actual)
    Study completion Jul 31, 2027→Apr 27, 2026 (now actual)
    Enrollment 60 (estimated)→77 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05876208
Responsible party
Brian Grawe (Principal Investigator, University of Cincinnati) — Principal investigator
First posted
May 25, 2023
Start date
Jul 5, 2022
Primary completion
Apr 27, 2026
Completion
Apr 27, 2026
Last update
Oct 16, 2026

Study contacts

Brian M Grawe, MD
principal investigator · University of Cincinnati

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion